MODIFIZIERTE TGF-BETA2-OLIGONUKLEOTIDE

Patent europeic · EP2978844 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2978844
Numer da la dumonda
EP14713127
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
27-03-2014
Publitgà
03-02-2016
Concedì
12-08-2020
La protecziun finescha il pli tard
26-03-2034
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
C12N 15/113 (2010.01)
C07H 21/00 (2006.01)
A61K 31/713 (2006.01)
A61P 35/00 (2006.01)
A61P 37/00 (2006.01)
A61P 27/02 (2006.01)
Prioritad
EP 13161474 27.03.2013
EP 13173078 20.06.2013
EP 13199838 30.12.2013
Dumonda PCT
PCT/EP2014/056232 27.03.2014
Publicaziun PCT
WO2014/154843 02.10.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 12-08-2020

    Concedì

    Published in Swissreg on 12.08.2020

Partidas

Possessur

ISARNA Therapeutics GmbH

Schellingstraße 109a, 80798 München, DE

Inventur

JASCHINSKI, Frank

82178 Puchheim, DE

JANICOT, Michel

B-1180 Brussels, BE

UHLMANN, Eugen

D-61479 Glashütten, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.